Overall rank by patents
#37,224
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Redyns Medical Llc
USPTO PatentsView assignee record - 7 granted patents across 3 technology areas, active 2015–2018. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
7
Total patents granted
3
CPC technology areas
14.0
Avg claims per patent
-100%
5-year filing velocity
The verdict
Redyns holds 7 US patents across 3 technology areas, rank #37,224 of 50,000 tracked assignees.
- #37,224
- of 50,000 US assignees by volume
- Top 91%
- by Innovation Score (21.7/100)
- 14.0
- avg claims per patent
- -100%
- filing velocity, last 5 yrs
Portfolio overview
Redyns Medical Llc has been granted 7 US utility patents between 2015 and 2018, placing Redyns Medical Llc at rank #37,224 across all assignees tracked by PlainPatent. This portfolio spans 3 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.0 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Redyns Medical Llc is one of the more focused assignees in the PatentsView dataset. By volume, Redyns sits between Redflow R&D Pty Ltd (7 patents, rank #37,220) and Rejuvatek Medical, Inc. (7 patents, rank #37,228) - the closest US assignees by grant volume. The composite Innovation Score of 21.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 7 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Redyns Medical Llc's 14.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while specialization in 3 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Redyns Medical Llc against peers pursuing similar technology classes.
Who files at Redyns's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Redflow R&D Pty
RedFlow R&D Pty Ltd
7 patents
- Redsky
RedSky Technologies, Inc.
7 patents
- Redbud Labs
Redbud Labs, Inc.
7 patents
- Redline Innovatio…
Redline Innovations, Inc
7 patents
- Reed Semiconductor
Reed Semiconductor Corporation
7 patents
- Reekon Tools
Reekon Tools Inc.
7 patents
- Regent Craft
Regent Craft, Inc.
7 patents
- Rejuvatek Medical
Rejuvatek Medical, Inc.
7 patents
- Redyns Medical ◀
Redyns Medical LLC
7 patents
What this shows Redyns holds 7 patents at rank #37,224, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Redyns
By rank, the assignees closest to #37,224 in granted patent volume.
- Redflow R&D Pty Ltd #37,220 · 7 patents
- Redsky Technologies, Inc. #37,221 · 7 patents
- Redbud Labs, Inc. #37,222 · 7 patents
- Redline Innovations, Inc #37,223 · 7 patents
- Reed Semiconductor Corporation #37,225 · 7 patents
- Reekon Tools Inc. #37,226 · 7 patents
- Regent Craft, Inc. #37,227 · 7 patents
- Rejuvatek Medical, Inc. #37,228 · 7 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Redyns's primary technology class.
- Covidien Lp 5,709 in class
- Koniniklijke Philips N.v. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag Gmbh International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- Depuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Redyns's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
22 Top 91% higher than 9% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 42.9% |
| 2016 | 1 | 14.3% |
| 2017 | 2 | 28.6% |
| 2018 | 1 | 14.3% |
Which technologies does Redyns Medical Llc patent most?
Top 3 of 3 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Standard
Velocity Declining
Frequently Asked Questions
How many patents does Redyns Medical Llc hold?
Redyns Medical Llc holds 7 US granted patents filed between 2015 and 2018, spanning 3 technology areas.
What is Redyns Medical Llc's Innovation Score?
Redyns Medical Llc has an Innovation Score of 21.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Redyns Medical Llc focus on?
Redyns Medical Llc's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 7 patents. The company has filed patents in 3 CPC subclasses total.
Is Redyns Medical Llc's patent filing rate increasing or decreasing?
Redyns Medical Llc's recent filing velocity is -100% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Redyns Medical Llc's patents?
Redyns Medical Llc's patents average 14.0 claims each. This falls within the standard range, providing solid legal coverage.
How is the Redyns Medical Llc patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Redyns's 7 grants land it in the top 91% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Redyns ranks #37,224 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.